Success mileage: Investor confidence accelerates with growth focus
Company gains market share in its top three markets of North America, India, EU
Despite valuation concerns, brokerages believe the transaction is positive for the new entity
Business Standard examines the S&P BSE 200 group of stocks in which the two investor categories have shown the most confidence
IT, manufacturing laggards in Q4 so far
Robust performance buoyed by soaring AUM and stellar equity performance
Due to several headwinds, brokerages have reduced their earnings per share estimates for FY25 by 5-8%
By comparison, categories like wood panel and tile-bathware could report mid to high single-digit growth rates
The company is expected to increase its volumes in the March quarter by 9% Y-o-Y on the back of market share gains in N India
Here are 10 stocks, covered by at least 10 brokerages, which are most likely to zoom based on their price target over the next year
Domestic firms may outperform exports in March quarter and in FY25
Yet, positioned for revenue growth with recent strong deals, driven by a strengthening US economy
Firm may face tough times amid forecast of weak box-office collections
In the past a rise in crude oil prices has resulted in lower corporate margins and profits
Even as the top pharmaceutical peers delivered a double digit growth in the December quarter, sales for GSK Pharma at Rs 805 crore was flat
Cheaper raw material prices and growth in premium segment expected to help company
Alchemy of revival: Early recovery catalysts blend with stable prices and eased supplier tensions
Brokerages are positive on the stock given its attractive valuations and expect a re-rating if there is value unlocking for its IPL franchise
The selloff in the small and midcap stocks has led to a moderation in valuation in the segment
Airline maps out its FY25 route, powered by double-digit pax growth, 11-13% year-on-year capacity boost, and expansion into 10 new destinations